Patents by Inventor Thomas Kapsner

Thomas Kapsner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases
    Patent number: 11261205
    Abstract: The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: March 1, 2022
    Assignee: Morphochem GmbH
    Inventors: Thomas Kapsner, Axel Dalhoff, Thomas Gramatte
  • OXAZOLIDINONE-QUINOLONE HYBRID ANTIBACTERIAL FOR THE PARENTERAL TREATMENT OF PROPHYLAXIS OF BACTERIAL DISEASES
    Publication number: 20200392168
    Abstract: The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
    Type: Application
    Filed: June 22, 2020
    Publication date: December 17, 2020
    Inventors: Thomas KAPSNER, Axel DALHOFF, Thomas GRAMATTE
  • Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases
    Patent number: 10723746
    Abstract: The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: July 28, 2020
    Assignee: Morphochem Aktiengesellschaft Für Kombinatorische Chemie
    Inventors: Thomas Kapsner, Axel Dalhoff, Thomas Gramatte
  • COMBINATION THERAPY COMPRISING OXAZOLIDINONE-QUINOLONES FOR USE IN TREATING BACTERIAL INFECTIONS
    Publication number: 20190111046
    Abstract: The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.
    Type: Application
    Filed: June 11, 2018
    Publication date: April 18, 2019
    Inventors: Thomas Kapsner, Axel Dalhoff
  • Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
    Patent number: 9993469
    Abstract: The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: June 12, 2018
    Assignee: Morphochem Aktiengesellschaft Für Kombinatorishe Chemie
    Inventors: Thomas Kapsner, Axel Dalhoff
  • OXAZOLIDINONE-QUINOLONE HYBRID ANTIBACTERIALS FOR THE PARENTERAL TREATMENT OR PROPHYLAXIS OF BACTERIAL DISEASES
    Publication number: 20160130288
    Abstract: The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
    Type: Application
    Filed: May 9, 2014
    Publication date: May 12, 2016
    Applicant: MORPHOCHEM AKTIENGESELLSCHAFT FÜR KOMBINATORISCHE CHEMIE
    Inventors: Thomas Kapsner, Axel Dalhoff, Thomas Gramatte
  • COMBINATION THERAPY COMPRISING OXAZOLIDINONE-QUINOLONES FOR USE IN TREATING BACTERIAL INFECTIONS
    Publication number: 20160113921
    Abstract: The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.
    Type: Application
    Filed: May 24, 2014
    Publication date: April 28, 2016
    Inventors: Thomas Kapsner, Axel Dalhoff